Cellgram-CKD (allogeneic bone marrow-derived mesenchymal stem cells) / Pharmicell - LARVOL DELTA

Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study (clinicaltrials.gov) - P=N/A | N=10 | Active, not recruiting | Sponsor: Pharmicell Co., Ltd. | Not yet recruiting ➔ Active, not recruiting | Trial primary completion date: Dec 2022 ➔ Mar 2027

Enrollment closed • Trial primary completion date • Chronic Kidney Disease • Nephrology • Renal Disease

Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease (clinicaltrials.gov) - P1 | N=10 | Completed | Sponsor: Pharmicell Co., Ltd. | Recruiting ➔ Completed | Trial completion date: Apr 2023 ➔ Sep 2023 | Trial primary completion date: Apr 2023 ➔ Sep 2023

Trial completion • Trial completion date • Trial primary completion date • Chronic Kidney Disease • Nephrology • Renal Disease

Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study (clinicaltrials.gov) - P=N/A; N=10; Not yet recruiting; Sponsor: Pharmicell Co., Ltd.

Clinical • New trial • Chronic Kidney Disease • Nephrology • Renal Disease

Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease (clinicaltrials.gov) - P1; N=10; Recruiting; Sponsor: Pharmicell Co., Ltd.; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Chronic Kidney Disease • Nephrology • Renal Disease

Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease (clinicaltrials.gov) - P1; N=10; Not yet recruiting; Sponsor: Pharmicell Co., Ltd.

Clinical • New P1 trial • Chronic Kidney Disease • Nephrology • Renal Disease